Literature DB >> 7628623

The three-dimensional structure of thymidine kinase from herpes simplex virus type 1.

K Wild1, T Bohner, A Aubry, G Folkers, G E Schulz.   

Abstract

Recombinant thymidine kinase from Herpes simplex virus type 1 (ATP:thymidine 5'-phosphotransferase; EC 2.7.1.21), an enzyme of therapeutic importance, was purified and crystallized in an N-terminally truncated but still fully active form. The three-dimensional structure was solved by X-ray diffraction analysis at 3.0 A resolution using isomorphous replacement. The chain fold is presented together with the bound substrates thymidine and ATP. Three chain segments at the surface could not be located. The chain fold, the location of the substrates and presumbly also the catalytic mechanism resemble the well-known adenylate kinases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628623     DOI: 10.1016/0014-5793(95)00680-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.

Authors:  Anthony Griffiths; Malen A Link; Caroline L Furness; Donald M Coen
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Structures of thymidine kinase 1 of human and mycoplasmic origin.

Authors:  Martin Welin; Urszula Kosinska; Nils-Egil Mikkelsen; Cecilia Carnrot; Chunying Zhu; Liya Wang; Staffan Eriksson; Birgitte Munch-Petersen; Hans Eklund
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

3.  Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.

Authors:  Michael I Besecker; Caroline L Furness; Donald M Coen; Anthony Griffiths
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

4.  The structure of bovine mitochondrial adenylate kinase: comparison with isoenzymes in other compartments.

Authors:  G J Schlauderer; G E Schulz
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

5.  Prediction of the binding mode of N2-phenylguanine derivative inhibitors to herpes simplex virus type 1 thymidine kinase.

Authors:  A C Gaudio; Y Takahata; W G Richards
Journal:  J Comput Aided Mol Des       Date:  1998-01       Impact factor: 3.686

6.  Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.

Authors:  M E Black; T G Newcomb; H M Wilson; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

7.  The effect of substrate binding on the conformation and structural stability of Herpes simplex virus type 1 thymidine kinase.

Authors:  C Wurth; U Kessler; J Vogt; G E Schulz; G Folkers; L Scapozza
Journal:  Protein Sci       Date:  2001-01       Impact factor: 6.725

8.  Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.

Authors:  Chenhong Luo; Akihiro Nawa; Youhei Yamauchi; Shinichi Kohno; Youko Ushijima; Fumi Goshima; Fumitaka Kikkawa; Yukihiro Nishiyama
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

9.  Crystal structure of bacteriophage T4 deoxynucleotide kinase with its substrates dGMP and ATP.

Authors:  A Teplyakov; P Sebastiao; G Obmolova; A Perrakis; G S Brush; M J Bessman; K S Wilson
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

10.  Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.

Authors:  Vladimir Ponomarev; Michael Doubrovin; Inna Serganova; Tatiana Beresten; Jelena Vider; Aleksander Shavrin; Ludmila Ageyeva; Julius Balatoni; Ronald Blasberg; Juri Gelovani Tjuvajev
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.